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ABSTRACT
Objectives: To describe implementation and results
from the National Health Service (NHS) Health Check
programme.
Design: Three-year observational open cohort study:
2009–2011.
Participants: People of age 40–74 years eligible for
an NHS Health Check.
Setting: 139/143 general practices in three east
London primary care trusts (PCTs) serving an
ethnically diverse and socially disadvantaged
population.
Method: Implementation was supported with
education, IT support and performance reports. Tower
Hamlets PCT additionally used managed practice
networks and prior-stratification to call people at higher
cardiovascular (CVD) risk first.
Main outcomes measures: Attendance, proportion
of high-risk population on statins and comorbidities
identified.
Results: Coverage 2009, 2010, 2011 was 33.9%
(31 878/10 805), 60.6% (30 757/18 652) and 73.4%
(21 194/28 890), respectively. Older people were more
likely to attend than younger people. Attendance was
similar across deprivation quintiles and was in
accordance with population distributions of black
African/Caribbean, South Asian and White ethnic
groups. 1 in 10 attendees were at high-CVD risk (20%
or more 10-year risk). In the two PCTs stratifying risk,
14.3% and 9.4% of attendees were at high-CVD risk
compared to 8.6% in the PCT using an unselected
invitation strategy. Statin prescription to people at high-
CVD risk was higher in Tower Hamlets 48.9%, than in
City and Hackney 23.1% or Newham 20.2%. In the
6 months following an NHS Health Check, 1349 new
cases of hypertension, 638 new cases of diabetes and
89 new cases of chronic kidney disease (CKD) were
diagnosed. This represents 1 new case of hypertension
per 38 Checks, 1 new case of diabetes per 80 Checks
and 1 new case of CKD per 568 Checks.
Conclusions: Implementation of the NHS Health
Check programme in these localities demonstrates
limited success. Coverage and treatment of those at
high-CVD risk could be improved. Targeting invitations
to people at high-CVD risk and managed practice
networks in Tower Hamlets improved performance.
INTRODUCTION
In England, the National Health Service
(NHS) Health Check is the ﬁrst programme
internationally aiming to improve cardiovas-
cular disease (CVD) risk factors in an entire
national adult population through behav-
ioural change and treatment informed by
CVD risk stratiﬁcation. Those eligible are
aged 40–74 years without diabetes or cardio-
vascular disease. The rolling 5-year pro-
gramme invites one-ﬁfth of the eligible
population annually, aiming for 3 million
people at a cost of £165 million.1–3 The
Department of Health report that 2.3 million
NHS Health Checks were undertaken in the
Strengths and limitations of this study
▪ Observational 3-year study of National Health
Service (NHS) Health Check implementation in
three of the most ethnically diverse and disad-
vantaged boroughs in the UK.
▪ In 2011, coverage averaged 73% with no evi-
dence of under-representation by black African/
Caribbean, South Asian or White ethnic groups
or deprivation quintile.
▪ One primary care trust (PCT) using prior risk
estimates for inviting the highest risk first, identi-
fied 66% more people at high risk. Overall, 1 in
10 people were at high-cardiovascular disease
risk and in these people statin prescription was
20%, 23% and 49% in the three PCTs,
respectively.
▪ One new case of hypertension was diagnosed
per 38 Health Checks, 1 case of diabetes per 80
Checks and 1 case of chronic kidney disease per
568 Checks.
▪ Implementation had ‘home advantage’ through a
single IT system supported by the University
Clinical Effectiveness Group. Additionally, Tower
Hamlets PCT managed practice networks con-
tributed to their programme success. There was
no control group and this study provides limited
evidence of effectiveness.
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2 years 2011–2012.4 Nationally, uptake is reported at
around 50% with considerable variability.4–6 Since 2013,
the programme has been supported by NHS England
and Public Health England, with commissioning trans-
ferred to the Local Authorities.7 8
There is no doubt that public health and legislative
measures on the causes of CVD are the major drivers for
improvement, including action on smoking, dietary satu-
rated fats, salt, sugars, alcohol, better air quality and safer
built environments promoting physical activity.9 Yet
despite huge gains since the epidemic peak in the 1970s,
CVD remains the greatest cause of premature death.
Treatment of people at highest CVD risk and health
promotion for the general population have a substantial
evidence base.10 In people at increased cardiovascular
(CVD) risk, primary prevention of CVD using multiple-
risk factor intervention, including treatment with statins
and antihypertensives, has been shown to be of
beneﬁt.11 For people at lower CVD risk, the efﬁcacy of
health checks remains unclear.12
The NHS Health Check programme aims to prevent
CVD events and detect diabetes, chronic kidney disease
(CKD) and hypertension. Stratiﬁcation of CVD risk to
guide treatment is a key component. At the time of the
study, National Institute for Health and Care Excellence
(NICE) guidance recommended statin treatment for a
10-year CVD risk of 20% or more, with appropriate man-
agement of new comorbidities.13 14
We describe implementation of the NHS Health
Check programme in Newham, Tower Hamlets and City
and Hackney Primary Care Trusts (PCTs). In 2013, PCTs
became Clinical Commissioning Groups and responsibil-
ity for the NHS Check Programme was transferred to
local authorities, and NHS England and Public Health
England. These organisations serve some of the most
ethnically diverse and socially deprived populations in
the UK and 50% of the population of 850 000 people
were from ethnic minority groups, of whom 30% are
South Asian and 10% are black African/Caribbean.
These three boroughs are in the top 1% of UK depriv-
ation. Levels of premature cardiovascular death are
among the highest in England, almost twice that of the
English average, and higher in South Asians for whom
type 2 diabetes is a major risk factor for CVD.15 High
turnover of patients, extended overseas visits and
changes of address and language compound the com-
plexities of programme delivery.
This study describes the ﬁrst 3 years implementation
of the NHS Health Check programme, 2009–2011, in
three entire PCTs, coverage and characteristics of those
who attended, the distribution and management of CVD
risks and the new identiﬁed comorbidities.
METHODS
Data extraction and analysis
This was a retrospective 3-year observational study on an
open cohort of patients eligible for an NHS Check,
based on data routinely entered by primary care staff in
electronic health records 2009–2011.
All but four of the 143 general practitioner (GP) prac-
tices in the three PCTs used the same web-enabled GP
electronic health record (EMIS Web). These
web-enabled GP practices cover 98% of 850 000 people
registered with local general practices. The other four
practices took part in the NHS Health Check pro-
gramme, but for technical reasons were not able to
provide study data.
In 2012, the Clinical Effectiveness Group QMUL
extracted anonymised patient level data from these
electronic health records in 139 out of a total of all
143 general practices that serve the boroughs of
Newham, City and Hackney and Tower Hamlets. Data
for each of the ﬁrst 3 years of the NHS Health Check
programme from April 2009/2010 to April 2011/2012
were extracted.
The study plan conformed to the STROBE recom-
mendations.16 All data extracted were anonymous and
based on routine data sources. Approval by an ethics
committee was not necessary. The data was analysed
using STATA V.10 (STATA Corps) and χ2 tests were used
to compare proportions.
Implementation of the NHS Health Checks
NHS Health Checks were largely undertaken by general
practice-based Health Care Assistants ﬁrst employed in
2009 and trained to undertake NHS Health Checks.
Practice nurses or GPs also did some Checks.
The NHS Health Check typically took 20–30 min.
10-year risk of CVD was estimated using QRisk2 (http://
www.qrisk.org), and fully integrated with the GP elec-
tronic health record in all study practices. Blood was
taken for serum total cholesterol and high-density lipo-
protein cholesterol with additional tests in those at
high-CVD risk for glycaemia, renal and liver function
and glycaemia in those with a body mass index of 30 or
more. Alcohol consumption with appropriate advice was
included but not nationally recommended at the time.
Attendees were advised on modiﬁcation of amelior-
able risk factors. Appointments with GP clinical staff
were made for further management of risk factors and
referrals were made to local providers supporting behav-
ioural change for smoking, diet, physical activity and
alcohol use.13
People at high-CVD risk (those with a 10-year CVD risk
of 20% or more) were considered for statin treatment.
Patients with risk factors such as abnormal glycaemia,
raised blood pressure, abnormal estimated-glomerular ﬁl-
tration rate (eGFR) or liver function tests were investi-
gated for potential comorbid diagnoses, including
hypertension, diabetes, chronic kidney or liver disease.
Continuing annual follow-up of those at high-CVD risk
was advised either as part of an established treatment
pathway (hypertension, chronic kidney disease, diabetes)
or as an ongoing annual review of high-CVD risk status;
however, only in Tower Hamlets and City and Hackney
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did this follow-up receive a ﬁnancial incentive in the
study period.
The Clinical Effectiveness Group (CEG) is a quality
improvement group led by academic GPs based in the
local University, funded at the time by the three PCTs
and currently by the Clinical Commissioning Groups
that succeeded them in 2013, to support a range of
improvement initiatives. CEG supported implementation
of the NHS Health Check programme, producing local
guidelines summarising national policies and educa-
tional meetings. CEG also developed IT support with a
standard on-screen data entry template to ensure that a
standard codeset was used in every practice. This estab-
lished a robust system for accurate data capture, regular
feedback of performance dashboards and payment
reports, and creation of standardised searches for prac-
tice call/recall systems. In Tower Hamlets, performance
dashboards were also reported at the network level. The
local NHS Health Check 2009 guideline and data entry
templates are available on the CEG website. http://
blizard.qmul.ac.uk/ceg-resource-library.html
CEG also organised prior estimates of CVD risk by
using QRisk2 in all eligible patients in each practice in
Tower Hamlets and City and Hackney, as described
below.
Differences between PCTs
In all three PCTs, the implementation of the pro-
gramme was supported by local schemes which paid GPs
to undertake the NHS Health Checks. City and Hackney
paid £12, £27 or £44 depending on whether the identi-
ﬁed 10-year CVD risk was 0–9%, 10–19% or 20% or
more. Payment for NHS Health Checks in Newham in
the initial 6-month was £50 to encourage start-up of the
programme and then reduced to £35. Both Hackney
and Tower Hamlets (but not Newham) ﬁnancially incen-
tivised targets for coverage, for the proportion of high-
risk individuals on statins and for follow-up of those at
high-CVD risk who were not already on existing hyper-
tension or other management programmes. In Tower
Hamlets, GPs were initially paid £11 per completed
Check, but practices were also funded to employ 1–2
trained Healthcare Assistants depending on practice
size. From 2010, the programme in Tower Hamlets was
additionally supported by the formation of managed
practice networks, described below, with ﬁnancial incen-
tives paid on the basis of network achievement of targets
rather than individual practice performance. If targets
were met, Tower Hamlets paid £32 per completed
Check.
There were other differences between implementation
in the three PCTs. In Tower Hamlets and City and
Hackney in 2009, CEG estimated prior CVD risk in every
eligible patient based on data in their medical record so
that those at highest risk could be called ﬁrst. Practices
subsequently varied in the extent to which they used this
facility to update the risk estimates; this was most com-
plete in Tower Hamlets. Newham started their
programme as a pilot 6 months before the April 2009
national start date. Prior stratiﬁcation of risk was not pos-
sible in Newham until 2011/2012. Therefore, in Tower
Hamlets and City and Hackney, patients at highest risk
were selected ﬁrst for invitation whereas little or no strati-
ﬁcation took place in Newham. Network managers
ensured that stratiﬁed invites were most complete in
Tower Hamlets, while in Hackney it was more variably
implemented.
In Newham, but not the other PCTs, cholesterol and
random blood glucose measurement were undertaken
as point of care testing in all attendees. In the other two
PCTs, samples were sent to hospital laboratories and
fasting blood glucose was selectively taken in people who
were obese or at high-CVD risk.
In Newham, ﬁve pharmacies carried out some NHS
Health Checks and in each of the PCTs a small number
of Checks were provided in community settings. These
comprised fewer than 2% of total NHS Health Checks.
The results of these Checks were intended to be
recorded in the GP records, but the results cannot be
separately identiﬁed to assess the completeness of
recording.
Tower Hamlets managed practice networks
Tower Hamlets PCT established managed practice net-
works in 2009, grouping general practices into geo-
graphical networks of 4–5 practices serving populations
of 30 000–50 000; each had a network manager to
deliver four care packages—diabetes, childhood immun-
isation, chronic lung disease and CVD. NHS Health
Checks were one element of the CVD care package fully
implemented in 2010, with payment for 3 key perform-
ance indicators: NHS Check coverage, statin usage in
people at high-CVD risk and follow-up of those at
high-CVD risk. These managed practice networks pro-
duced a step-change in performance for Tower Hamlets
which was the top CCG in England in 2012/2013 across
a range of measures for diabetes, COPD and CVD in the
national Quality and Outcomes Framework and national
diabetes audit, and top in London for childhood
immunisation.17–19
Definitions of variables used
The current Department of Health (DOH) deﬁnition of
the eligible population includes people aged 40–74 years
and excludes those with pre-existing coronary heart
disease, stroke/transient ischaemic attack, peripheral
vascular disease, heart failure, atrial ﬁbrillation, hyper-
tension, diabetes, familial hypercholesterolaemia, CKD
stages 3–5 and people already on statins.
Ethnic group data was based on self-reported ethnicity
recorded in the GP electronic health record. For the
purposes of this study, data were grouped by 2001
Census category: white (British, Irish, other white);
South Asian (Bangladeshi, Indian, Pakistani, other
Asian); black (African, Caribbean, black British); other
(any other recorded ethnic group including mixed
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ethnic groups) and not stated (ethnicity could not be
classiﬁed from the recorded entry). Those without a
record were categorised as not recorded. Over 90% of
the adult population in these PCTs had a GP record of
their self-reported ethnic group.
New comorbidity was deﬁned as a new diagnosis of
hypertension or diabetes recorded within 6 months of
the Health Check, and not simply a raised blood pres-
sure or hyperglycaemia. CKD was deﬁned by an eGFR of
less than 60 mL/min/1.73 m2. Statin prescription was
any prescription recorded following an NHS Check.
Deprivation was assessed using the Townsend score
accessed for 99% of patients, based on 2001
Census-derived measures of overcrowding, car ownership
and education available at lower super output area;
approximately 150 households.
Invitations for NHS Health Checks were not recorded
as no codes for invitation existed in the initial years. In
this study, coverage is deﬁned as the proportion of one-
ﬁfth of the total eligible population in that year who
attended for an NHS Health Check. In other words, if
14% of the total eligible population attended in 1 year,
that represents a coverage of 14/20=70%. This differs
from current NHS England reports of uptake, deﬁned
as attendees as a proportion of those invited to attend.
The programme was implemented at varying start
dates in the three PCTs. In Newham, it was started in
2008, 6 months before the ofﬁcial start on 1 April 2009.
In Tower Hamlets, and City and Hackney, the implemen-
tation was not complete in all practices until 2010.
RESULTS
Table 1 shows that in the years April 2009–2011 across
all three PCTs, 50 651 people attended an NHS Health
Check. This represents 6.8%, 12.1% and 14.7% of the
total eligible population in each successive year, equiva-
lent to coverage of 33.9% (31 878/10 805), 60.6%
(30 757/18 652) and 73.4% (21 194/28 890) in each
year, respectively. By 2011/2012, Newham and Tower
Table 2 Total eligible and total attendees; numbers and proportions of these aged 60–74; 2011/2012
Total eligible 40–74 years
N
Eligible 60–74 years Total attendees
Attendees
60–74 years
N Total (%) 40–74 years N Total (%)
Tower Hamlets 40 611 4011 9.9 6909 1011 14.6
City and Hackney 58 390 6723 11.5 6939 1258 18.1
Newham 45 450 4796 10.6 7346 869 11.8
All 3 PCTs 144 451 15 530 10.8 21 194 3138 14.8
PCTs, Primary Care Trusts.
Table 1 Total eligible population (EP), number and proportion of attendees and coverage*
Year Total EP Attendees EP attended (%) Coverage (%)
Newham
2009–2010 51 353 8477 16.5 82.5
2010–2011 46 980 6310 13.4 67.2
2011–2012 45 450 7346 16.2 80.8
Total 22 133
City and Hackney
2009–2010 63 258 730 1.2 5.8
2010–2011 62 930 6759 10.7 53.7
2011–2012 58 390 6939 11.9 59.4
Total 14 428
Tower Hamlets
2009–2010 44 779 1598 3.6 17.8
2010–2011 43 875 5583 12.7 63.6
2011–2012 40 611 6909 17.0 85.1
Total 14 090
All 3 PCTs
2009–2010 159 390 10 805 6.8 33.9
2010–2011 153 785 18 652 12.1 60.6
2011–2012 144 451 21 194 14.7 73.4
Total 50 651
*Coverage is calculated as attendees divided by one-fifth of the eligible population.
PCTs, Primary Care Trusts.
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Hamlets had coverage of 82.5% and 85.1%, respectively,
and City and Hackney of 59.4%.
Characteristics of attendees
Table 2 shows that attendees at an NHS Health Check
were signiﬁcantly older than would be expected from
their distribution in the eligible population. Over all
three PCTs in 2011/2012, people aged 60 years or more
comprised 14.8% of NHS Health Check attendees com-
pared to 10.8% in the eligible population (p<0.001).
Owing to the strategy of calling people at high-CVD
risk ﬁrst, older people were more likely to attend in
Tower Hamlets, and City and Hackney than in Newham.
In Newham, 2011/2012, people aged 60 years or more
comprised 11.8% of attendees compared to 10.6% of
those in the eligible population. In City and Hackney, of
the 2011/2012 attendees, aged 60 years and over com-
prised 18.1% compared to 11.5% of those in the eligible
population and in Tower Hamlets, this age group com-
prised 14.6% of attendees compared to 9.9% in the eli-
gible population.
Table 3 shows that attendance among black African/
Caribbean, South Asian and White ethnic groups was
similar to their representation in the eligible population
and no group was under-represented. Attendance by
‘Other’ ethnic groups and in particular, by those
without ethnic group recorded were lower than
expected. In 2011–2012, over all three PCTs, the propor-
tion of black African/Caribbean people in the eligible
population and their proportion among attendees com-
prised 19.8% and 21.6%, respectively; proportion for
South Asian was 15.4% and 23.6%; White 42.2% and
46.9%; Other 8.5% and 6.8%; Not Recorded 14.2% and
0.1%, respectively.
Across all three PCTs, the coverage was similar across
all deprivation groups and those in the most deprived
quintile comprised 82% of attendees and 80% of the
eligible population.
CVD risk
Over the period 2009–2011, QRisk2 was recorded in
94.1% (47 648/50 651) attendees at an NHS Health
Check and 56.8% (231 158/406 975) of non-attendees.
Among those with a QRisk2 recording, high-CVD risk
was recorded in 10.5% (4990/47 648) of attendees and
5.1% (11 794/231 158) of non-attendees.
The number and proportion of attendees by CVD risk
categories are recorded in table 4 for the three com-
bined PCTs over all the 3 years; 33.3% of attendees were
at 10% or more CVD risk, and 10.5% were at 20% or
more CVD risk.
Table 5 shows the proportions of attendees who were
at high-CVD risk (QRisk2 20% or more 10-year risk) in
each of the 3 years. As people at highest CVD risk
tended to be selected ﬁrst in Tower Hamlets, and City
and Hackney, there were relatively more attendees at
high CVD risk in earlier years. By the third year of the
programme, there was less difference between PCTs in
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the proportion identiﬁed at high-CVD risk. However,
over all 3 years, City and Hackney, which operated a
selective strategy, identiﬁed more people at high-CVD
risk 9.4% than Newham 8.6%, p<0.01; Tower Hamlets
14.3%, identiﬁed signiﬁcantly more than either of the
other PCTs, p<0.001. In relative terms, this targeted strat-
egy identiﬁed 66% more people at high-CVD risk in
Tower Hamlets than an unselected strategy in Newham.
QRisk2 in Tower Hamlets and City and Hackney was
estimated for the entire eligible population in the ﬁrst
year of the programme and practices were encouraged
to maintain this. In these PCTs, the proportion of non-
attendees with QRisk2 recorded in 2009/2010 was
87.1% and 87.9%, respectively, and by 2011/2012 this
had fallen to 76.1% and 40.7%, respectively. In Newham
in 2009/2010, 21.7% of non-attendees had QRisk2
recorded and this increased to 45.2% in 2011/2012 as
some practices in Newham adopted prior stratiﬁcation
in the latter year.
Treatment in people at high risk
There were marked differences between the three PCTs
in the proportion of people at high-CVD risk prescribed
statins shown in table 6. Prescription of statins to people
at high-CVD risk in 2009–2011 was consistently higher in
Tower Hamlets 48.9% than in the other two PCTs; City
and Hackney 23.1%, and Newham 20.2%. Across all
three PCTs combined in the years beginning 2009–2011,
the proportion at high-CVD risk prescribed statins was
similar at 34.6%, 30.9% and 31.9%. Less than 1% had a
statin contraindication recorded.
New comorbidities
In the three PCTs in the years 2009–2011, there were a
total of 50 651 NHS Health Checks and in the 6 months
following, 1349 new cases of hypertension were diag-
nosed as were 638 new cases of diabetes and 89 new
cases of CKD. This represents one new case of
hypertension per 38 Checks, one new case of diabetes
per 80 Checks, and one new case of CKD per 568
Checks.
Table 7 shows the new comorbidities identiﬁed within
6 months per 1000 NHS Health Checks. Tower Hamlets
had higher rates of newly identiﬁed hypertension and
CKD than the other two PCTs (p<0.001). The incidence
of new diabetes diagnoses was similar in Tower Hamlets
and Newham despite the fact that Newham has a higher
background prevalence of diabetes and blood glucose
testing was undertaken at all NHS Health Checks in
Newham; Tower Hamlets restricted tests to a higher risk
group.
DISCUSSION
This is the most extensive report of the NHS Health
Check programme to date, describing implementation
and ﬁrst 3 years results in three entire local health
economies.
Differences in implementation between PCTs permit
some comparative assessment of identiﬁed comorbidities
and statin prescription. All three PCTs actively supported
the programme with ﬁnancial incentives, staff training,
educational programmes, IT support and feedback of
performance. Tower Hamlets achieved the best results
with additional support through managed practice net-
works in combination with prior risk stratiﬁcation.
In the 3 years 2009–2011, 6.8%, 12.1% and 14.7% of
the eligible population aged 40–74 years attended an
NHS Health Check, representing coverage of 33.9%,
60.5% and 73.5%, respectively. This is comparable to
coverage by the well-established national breast screen-
ing programme, with London uptake of 64% in 2010/
2011 and cervical screening in east London of 72% in
2010/2011; these exceeded the 40% uptake of the more
recently established bowel screening programme.20 21
Other studies report improved uptake from the synergy
of GP practice based support for recall systems.22
Table 5 Attendees in the high-CVD risk group by year and PCT.
2009 2010 2011 All years
Newham 9.2% 733 8.2% 458 8.1% 524 8.6% 1715
City and Hackney 23.6% 150 9.9% 640 7.8% 538 9.4% 1328
Tower Hamlets 31.3% 484 16.5% 882 8.6% 581 14.3% 1947
All PCTs 13.4% 1367 11.4% 1980 8.2% 1643 10.5% 4990
%; Number 2009–2011.
CVD, cardiovascular disease; NHS, National Health Service; PCTs, primary care trusts.
Table 4 People attending an NHS Health Check by CVD 10-year risk (QRisk2)
CVD risk 0−<5% 5−<10% 10−<15% 15−<20% 20%+ All
Per cent in risk group 40.3% 26.4% 14.3% 8.5% 10.5% 100%
Number 19 203 12 569 6811 4075 4990 47 648
Three PCTs 2009–2011; %, Number
CVD, cardiovascular disease; NHS, National Health Service.
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By 2011, 20 000 people attended annually for an NHS
Health Check in these three PCTs and in total 50 651
people attended since 2009. The level of coverage in
2011 was 85% in Tower Hamlets though coverage was
similarly high in Newham, where the PCT had been par-
ticularly proactive with ﬁnancial and facilitative support.
There was no evidence of underprovision for older
people, those in the major ethnic minority groups or for
the most deprived quintiles. Under-representation of
other ethnic groups and those without ethnicity
recorded is likely to be due to people who had left the
practice or no longer lived at their stated address.
Over the study period, 1 in 10 attendees were at
high-CVD risk (20% or more 10-year risk). In Tower
Hamlets and City and Hackney PCTs which per-stratiﬁed
invitations, 14.3% and 9.4% of attendees were at high
risk compared to 8.6% using an unselected strategy in
Newham (p<0.01). In Tower Hamlets, this represents a
66% increase in attendance from among those at
high-CVD risk in comparison to an unselected strategy
in Newham.
The prior risk estimates depend on regular annual
practice updates as new patients join or age, and risks
change. Over a full 5-year cycle, prior estimation of risk
may represent a more efﬁcient method of identifying
those at highest risk, but would require support to
encourage practices to run regular updates; alternatively
age is a simple initial proxy for risk.
Comparison with other studies
In 2011, coverage in east London of 73% was higher
than other reported studies. National PCT reports indi-
cate that uptake (based on attendance among those
invited) in England was 51% in 2011. Twenty-seven of
151 PCTs nationally offered NHS Health Checks to
fewer than 10% of eligible individuals.23 This reﬂects
reports of uncertainty about the organisation, ﬁdelity
and implementation of NHS Health Checks, available
codesets and of the accuracy of PCT reports of the eli-
gible denominator population in the early years of the
programme.5 24 There has since been standardisation of
reporting.25
Earlier studies on NHS Health Checks in people at
high-CVD risk reported similarly higher proportions of
older people attending and similarly no under-
representation among the South Asian or black African/
Caribbean groups, with an uptake of 20–45% and
marked practice variation.26 27 Data from Stoke on Trent
found higher response among more afﬂuent people.28
A study in one PCT, 2008/2009, in high-risk people
described a reduction in CVD risk factors 1 year after an
NHS Health Check and statin prescription increased
from 16% to 60%.29
The 10.5% at high-CVD risk in our study is similar to
the proportion reported in these studies from similar
populations, but higher than the national average of
8.4% reﬂecting the higher levels of social deprivation
and South Asian ethnicity in studies from inner
London.30 31
In our study 32% of people at high-CVD risk were pre-
scribed statins. In an English nationally representative
study, Van Staa32 also found that 32% of those at
high-CVD risk in 2010 were prescribed statins. Like Van
Staa, we found marked differences in statin prescribing
between PCTs. Twice as many people in Tower Hamlets
were prescribed statins 49%, than in City and Hackney
23% or Newham 20%. Other UK studies have shown
rates of statin treatment of 45% and 53% in selected
people at high-CVD risk26 27 and in New Zealand, statin
use is between 20 and 32%.33
Table 7 New diagnoses of hypertension, diabetes and CKD within 6 m of NHS Health Check by PCT 2009–2011
PCT
Hypertension Diabetes CKD 3–5 Total
Rate N Rate N Rate N attendees
Newham 22.7 503 14.4 318 1.7 37 22 133
City and Hackney 23.5 339 9.2 133 0.8 11 14 428
Tower Hamlets 36.0 507 13.3 187 2.9 41 14 090
All 3 PCTs 26.6 1349 12.6 638 1.8 89 50 651
Rate per 1000 Health Checks, number.
CKD, chronic kidney disease; NHS, National Health Service; PCTs, Primary Care Trusts.
Table 6 Percentage of attendees at high-CVD risk prescribed a statin, by PCT and year
2009–2010
Attendees (%)
2010–2011
Attendees (%)
2011–2012
Attendees (%)
2009–2011
All Attendees (%)
Newham 25.2 16.4 16.4 20.2
City and Hackney 27.3 22.2 23.8 23.2
Tower Hamlets 51.0 44.8 53.4 48.9
All 3 PCTs 34.6 30.9 31.9 32.2
PCTs, Primary Care Trusts.
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The identiﬁcation of new comorbidities has been a
successful element of this current programme. One new
case of diabetes was identiﬁed for every 80 Checks
carried out and 1 new case of hypertension for every 38
Checks carried out. New comorbidities will be detected
in primary care in the absence of NHS Health Checks
and the ‘additional’ cases identiﬁed have not been esti-
mated in this evaluation as this would be more appropri-
ate to consider in a full 5-year cycle of the programme.
Existing strategies to detect diabetes may still be subopti-
mal and speciﬁc risk scores to target diabetes or renal
risk may improve detection rates.34–36
Differences between study PCTs
The relatively high rate of statin prescription in Tower
Hamlets was inﬂuenced by two factors. First, Tower
Hamlets targeted people in the highest risk categories.
Those people with CVD risks as high as 40% or 50%, for
example, will be older or have a positive family history of
premature heart attack, obesity or South Asian ethnic
group, each of which may positively inﬂuence percep-
tion of risk and take-up of statin treatment.37 38 Second,
managed practice networks produced a step-change in
local performance in Tower Hamlets.
All three PCTs had similar levels of core support from
the Clinical Effectiveness Group. Tower Hamlets and
City and Hackney additionally targeted high-risk people.
In Newham, an early 2008 start and higher ﬁnancial
incentives promoted rapid adoption of the programme.
In Tower Hamlets, the NHS Health Check programme
was incorporated into the Tower Hamlets managed prac-
tice network scheme with targets for coverage, statins
and follow-up of people at high-CVD risk.
Although Newham achieved similar coverage to Tower
Hamlets, their programme did not target people at
high-CVD risk and this led to the identiﬁcation of a
lower risk group; 8.6% at high-CVD risk compared to
14.3% in Tower Hamlets. This is likely to be one of the
main reasons why relatively less hypertension and CKD
was identiﬁed in Newham and City and Hackney.
Managed practice networks are also likely to have con-
tributed to higher statin prescription in Tower Hamlets.
Diabetes identiﬁcation in Newham and Tower Hamlets
was similar because the prevalence of type 2 diabetes is
known to be highest in Newham where universal blood
glucose testing was used. (a more targeted strategy was
subsequently adopted in Newham as this proved an inef-
ﬁcient method of screening).
Strengths and weaknesses
Our between group comparisons used a simple χ2 test.
The use of multiple logistic regression would have given
greater precision, but would not have altered the above
conclusions. The ﬁrst 3-years of a programme assess-
ment may not reﬂect performance in a full 5-year cycle.
The study is based on almost all practices in three local-
ities rather than selected practices, giving a complete
picture of implementation. All three PCTs were
enthusiastic early adopters of the programme with ‘home
advantage’ support from the University-based Clinical
Effectiveness Group. The alignment of strategies—educa-
tion through guidelines and meetings, a single IT system
and performance feedback were key to synergistic
working. CEG produced guidelines, supported education
and Health Care Assistant training, designed standard
coding and data entry templates, decision support tools,
prior-stratiﬁcation invite lists together with training and
continuing support, including monthly identiﬁable prac-
tice performance reports on key indicators.
An unintended consequence of the NHS Check pro-
gramme was the employment and training of Health
Care Assistants. Many were GP reception and clerical
staff, keen to develop skills and capacity. They now form
an important part of the local workforce with broader
responsibilities and training formalised in National
Vocational Qualiﬁcation schemes.
Wider context of NHS Checks
Nationally, NHS Check implementation has been highly
variable and lower than expected. Higher uptake in
deprived areas reduces the possibility of exacerbation of
inequalities.6 39 In some CCGs nationally, uncertainty
about the beneﬁts of such programmes and claims that
health checks are ineffective may have contributed to a
lack of investment in new services at a time of reduced
NHS budgets. These views, which received a large amount
of media publicity critical of the NHS Check programme,
were based on studies now 20–30 years old, conducted in
very different settings before most effective treatments for
blood pressure, lipids and therapies for smoking cessation
were invented.40–43 More recently, major organisational
change in the NHS in 2013, when PCTs became Clinical
Commissioning Groups and responsibility for the pro-
gramme was transferred to local authorities at a time of
reduced budgets, have also been reported to have
impacted on implementation.44 A range of issues are cur-
rently being addressed by NHS England and Public
Health England.24 The transfer of commissioning respon-
sibility has not altered the CVD content of the NHS Check
and the ﬁndings of this study are relevant to current imple-
mentation of this programme.
CONCLUSION
The NHS Health Check programme was successfully
implemented across all primary care organisations in
three of the most disadvantaged boroughs in the UK,
achieving 73% annual coverage by 2011 and delivering
20 000 NHS Health Checks annually. Older people were
more likely to attend and attendance among black
African/Caribbean, South Asian and White ethnic
groups and all quintiles of deprivation reﬂected their
representation in the local population.
One in 10 of those attending an NHS Health Check were
at high-CVD risk, of whom 32% were prescribed statins,
with prescription higher in Tower Hamlets at 48.9%, than
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in the other two PCTs: City and Hackney 23.1% and
Newham 20.2%. One new case of hypertension per 38
Health Checks, 1 new case of diabetes per 80 Checks, and
1 new case of CKD per 568 Checks were identiﬁed.
PCTs inviting those at highest risk ﬁrst, identiﬁed
more people at high-CVD risk. Managed practice net-
works in Tower Hamlets were associated with the highest
levels of coverage, new comorbidity, high-CVD risk iden-
tiﬁcation and statin treatment.
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